Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Amryt Pharma Plc ADR (AMYT)

Amryt Pharma Plc ADR (AMYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 940,256
  • Shares Outstanding, K 63,963
  • Annual Sales, $ 222,540 K
  • Annual Income, $ 1,000 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.84
  • Price/Sales 4.00
  • Price/Cash Flow 14.98
  • Price/Book 2.90
  • Price/Earnings ttm 734.50
  • Earnings Per Share ttm -0.13
  • Most Recent Earnings $-0.06 on 11/03/22
  • Next Earnings Date 05/03/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/23
See More
  • Average Estimate 0.00
  • Number of Estimates 2
  • High Estimate 0.02
  • Low Estimate -0.02
  • Prior Year -0.05
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.52 +1.24%
on 03/16/23
14.76 -0.41%
on 04/11/23
+0.09 (+0.62%)
since 03/10/23
3-Month
14.52 +1.24%
on 03/16/23
14.77 -0.47%
on 01/13/23
-0.07 (-0.47%)
since 01/11/23
52-Week
6.41 +129.33%
on 06/21/22
14.77 -0.47%
on 01/13/23
+7.23 (+96.79%)
since 04/11/22

Most Recent Stories

More News
Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc

/PRNewswire/ -- Chiesi Farmaceutici S.p.A. ("Chiesi"), an international, research-focused biopharmaceuticals and healthcare group, today announced the...

AMYT : 14.70 (+0.07%)
AMYT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amryt Pharma Plc Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Amryt Pharma Plc (NASDAQ: AMYT) to Chiesi Farmaceutici S.p.A. is fair to Amryt shareholders. Per the terms of the proposed...

AMYT : 14.70 (+0.07%)
AMRYT PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amryt Pharma Plc - AMYT

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Amryt Pharma Plc (NasdaqGS: AMYT) to Chiesi...

AMYT : 14.70 (+0.07%)
Why Shares of Amryt Pharma Jumped This Week

A takeover bid by an Italian pharmaceutical and healthcare company boosted Amryt's shares.

AMYT : 14.70 (+0.07%)
AMRYT PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amryt Pharma Plc - AMYT

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Amryt Pharma Plc (NasdaqGS: AMYT) to Chiesi...

AMYT : 14.70 (+0.07%)
SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Amryt Pharma Plc - AMYT

/PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national...

AMYT : 14.70 (+0.07%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMYT, CINC, ALBO

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AMYT : 14.70 (+0.07%)
CINC : 29.06 (-0.48%)
ALBO : 44.15 (-0.23%)
AMYT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amryt Pharma Plc Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Amryt Pharma Plc (NASDAQ: AMYT) to Chiesi Farmaceutici S.p.A. is fair to Amryt shareholders. Per the terms of the proposed...

AMYT : 14.70 (+0.07%)
Amryt to Report Q2 2022 Results on August 4, 2022

DUBLIN, Ireland, and Boston MA, July 21, 2022, Amryt (Nasdaq: AMYT) a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing...

AMYT : 14.70 (+0.07%)
Amryt Receives Orphan Drug Designation from the FDA for Mycapssa® (oral octreotide) for the Treatment of Carcinoid Syndrome

Amryt Receives Orphan Drug Designation from the FDA for Mycapssa® (oral octreotide) for the Treatment of Carcinoid Syndrome DUBLIN, Ireland, and Boston...

AMYT : 14.70 (+0.07%)

Business Summary

Amryt Pharma plc is a biopharmaceutical company. It develops and commercializes therapeutics to treat rare diseases. Amryt Pharma plc is based in London, the United Kingdom.

See More

Key Turning Points

3rd Resistance Point 14.89
2nd Resistance Point 14.83
1st Resistance Point 14.76
Last Price 14.70
1st Support Level 14.63
2nd Support Level 14.57
3rd Support Level 14.50

See More

52-Week High 14.77
Last Price 14.70
Fibonacci 61.8% 11.58
Fibonacci 50% 10.59
Fibonacci 38.2% 9.60
52-Week Low 6.41

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar